Accutar Biotech, is a Shanghai and Brooklyn-based company. It employs artificial intelligence and protein crystallographic data for drug design to improve the accuracy and efficiency of screening drugs through 3D Molecular operators and deep chemical structure network calculations. The company has developed a data-driven atom-based scoring function that is learned from 100,000 protein crystal structures containing information of >100 million amino acid side chains; and a dynamic deep neural network specifically designed for chemical informatics.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2015
- Website
- www.accutarbio.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of AccutarBiotech?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now